Chronic constipation: New diagnostic and treatment approaches

Brian E. Lacy, John M. Levenick, Michael Crowell

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Chronic constipation is a highly prevalent disorder that affects approximately 15% of the US population. Chronic constipation refers to patients who have had symptoms for more than 6 months. In clinical practice, chronic constipation is often used interchangeably with the term functional constipation. This is best defined using the Rome III criteria, which involves an evaluation of stool frequency in addition to symptoms of straining, feelings of incomplete evacuation, and the need to use manual maneuvers to assist with stool evacuation. Symptoms can be burdensome, leading to a reduction in patients' quality of life. As a national healthcare issue, chronic constipation is also important because it imposes a significant economic impact on the healthcare system. A number of treatment options are currently available, both over-the-counter and by prescription, although not all patients respond to these therapies. This review will focus on new medical treatment options for the management of chronic constipation, and the safety and efficacy of these agents will be reviewed. In addition, the efficacy of new diagnostic tests to evaluate colonic motility and anorectal function are described.

Original languageEnglish (US)
Pages (from-to)233-247
Number of pages15
JournalTherapeutic Advances in Gastroenterology
Volume5
Issue number4
DOIs
StatePublished - Jul 2012

Fingerprint

Constipation
Therapeutics
Delivery of Health Care
Routine Diagnostic Tests
Prescriptions
Emotions
Economics
Quality of Life
Safety
Population

Keywords

  • anorectal manometry
  • constipation
  • guanylate cyclase
  • linaclotide
  • lubiprostone
  • plecanitide
  • prucalopride
  • Rome criteria
  • velusetrag
  • wireless motility capsule

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Chronic constipation : New diagnostic and treatment approaches. / Lacy, Brian E.; Levenick, John M.; Crowell, Michael.

In: Therapeutic Advances in Gastroenterology, Vol. 5, No. 4, 07.2012, p. 233-247.

Research output: Contribution to journalArticle

Lacy, Brian E. ; Levenick, John M. ; Crowell, Michael. / Chronic constipation : New diagnostic and treatment approaches. In: Therapeutic Advances in Gastroenterology. 2012 ; Vol. 5, No. 4. pp. 233-247.
@article{7e26b6c3420f482fae7fe47716d87057,
title = "Chronic constipation: New diagnostic and treatment approaches",
abstract = "Chronic constipation is a highly prevalent disorder that affects approximately 15{\%} of the US population. Chronic constipation refers to patients who have had symptoms for more than 6 months. In clinical practice, chronic constipation is often used interchangeably with the term functional constipation. This is best defined using the Rome III criteria, which involves an evaluation of stool frequency in addition to symptoms of straining, feelings of incomplete evacuation, and the need to use manual maneuvers to assist with stool evacuation. Symptoms can be burdensome, leading to a reduction in patients' quality of life. As a national healthcare issue, chronic constipation is also important because it imposes a significant economic impact on the healthcare system. A number of treatment options are currently available, both over-the-counter and by prescription, although not all patients respond to these therapies. This review will focus on new medical treatment options for the management of chronic constipation, and the safety and efficacy of these agents will be reviewed. In addition, the efficacy of new diagnostic tests to evaluate colonic motility and anorectal function are described.",
keywords = "anorectal manometry, constipation, guanylate cyclase, linaclotide, lubiprostone, plecanitide, prucalopride, Rome criteria, velusetrag, wireless motility capsule",
author = "Lacy, {Brian E.} and Levenick, {John M.} and Michael Crowell",
year = "2012",
month = "7",
doi = "10.1177/1756283X12443093",
language = "English (US)",
volume = "5",
pages = "233--247",
journal = "Therapeutic Advances in Gastroenterology",
issn = "1756-283X",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Chronic constipation

T2 - New diagnostic and treatment approaches

AU - Lacy, Brian E.

AU - Levenick, John M.

AU - Crowell, Michael

PY - 2012/7

Y1 - 2012/7

N2 - Chronic constipation is a highly prevalent disorder that affects approximately 15% of the US population. Chronic constipation refers to patients who have had symptoms for more than 6 months. In clinical practice, chronic constipation is often used interchangeably with the term functional constipation. This is best defined using the Rome III criteria, which involves an evaluation of stool frequency in addition to symptoms of straining, feelings of incomplete evacuation, and the need to use manual maneuvers to assist with stool evacuation. Symptoms can be burdensome, leading to a reduction in patients' quality of life. As a national healthcare issue, chronic constipation is also important because it imposes a significant economic impact on the healthcare system. A number of treatment options are currently available, both over-the-counter and by prescription, although not all patients respond to these therapies. This review will focus on new medical treatment options for the management of chronic constipation, and the safety and efficacy of these agents will be reviewed. In addition, the efficacy of new diagnostic tests to evaluate colonic motility and anorectal function are described.

AB - Chronic constipation is a highly prevalent disorder that affects approximately 15% of the US population. Chronic constipation refers to patients who have had symptoms for more than 6 months. In clinical practice, chronic constipation is often used interchangeably with the term functional constipation. This is best defined using the Rome III criteria, which involves an evaluation of stool frequency in addition to symptoms of straining, feelings of incomplete evacuation, and the need to use manual maneuvers to assist with stool evacuation. Symptoms can be burdensome, leading to a reduction in patients' quality of life. As a national healthcare issue, chronic constipation is also important because it imposes a significant economic impact on the healthcare system. A number of treatment options are currently available, both over-the-counter and by prescription, although not all patients respond to these therapies. This review will focus on new medical treatment options for the management of chronic constipation, and the safety and efficacy of these agents will be reviewed. In addition, the efficacy of new diagnostic tests to evaluate colonic motility and anorectal function are described.

KW - anorectal manometry

KW - constipation

KW - guanylate cyclase

KW - linaclotide

KW - lubiprostone

KW - plecanitide

KW - prucalopride

KW - Rome criteria

KW - velusetrag

KW - wireless motility capsule

UR - http://www.scopus.com/inward/record.url?scp=84863443935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863443935&partnerID=8YFLogxK

U2 - 10.1177/1756283X12443093

DO - 10.1177/1756283X12443093

M3 - Article

C2 - 22778789

AN - SCOPUS:84863443935

VL - 5

SP - 233

EP - 247

JO - Therapeutic Advances in Gastroenterology

JF - Therapeutic Advances in Gastroenterology

SN - 1756-283X

IS - 4

ER -